Home
JournalsCollections
For Authors For Reviewers For Editorial Board Members
Article Processing Charges Open Access
Ethics Advertising Policy
Editorial Policy Resource Center
Company Information Contact Us
OPEN ACCESS

Guillain-Barre Syndrome Following Viral Infections: Considerations for Future Treatment and Research

  • Lili Wang*
Exploratory Research and Hypothesis in Medicine   2018;3(1):4-5

doi: 10.14218/ERHM.2017.00035

Received:

Revised:

Accepted:

Published online:

 Author information

Citation: Wang L. Guillain-Barre Syndrome Following Viral Infections: Considerations for Future Treatment and Research. Explor Res Hypothesis Med. 2018;3(1):4-5. doi: 10.14218/ERHM.2017.00035.

As the world’s population grows in an explosive way, the circumstances we live in become more crowed than ever in human history. Although medicine and biotechnology have developed tremendously in the new century, the growing density of population has brought us unexpected challenges in public health. This not only causes the emergence of new viruses but also makes coinfection and super-infection more common than previously (Table 11–14). However, the symptoms of these infections, although severe and life threatening in extreme cases, share some common characteristics in outcomes. Many of them cause Guillain-Barré syndrome (GBS) and respiratory emergency. The case reported by Hariharan et al.15 has provided a good reference for the treatment outcomes of such conditions.

Table 1

Recent virus pandemics and their relationship to Guillain-Barré syndrome and respiratory distress syndrome

OutbreaksYearMay cause Guillain-Barré syndromeMay cause respiratory distress syndrome
Severe acute respiratory syndrome2002–2003UnknownYes1
Chikungunya2006Yes2Yes3
Zika virus in Yap Island, Federated States of Micronesia2007Yes4Unknown
H1N1 influenza2009–2010Yes5Yes6
Measles in Congo2010–nowUnknownYes7
Middle East respiratory syndrome2012–nowUnknownYes8
Zika virus in French Polynesia2013–2014Yes9Yes10
Chikungunya2013–nowYes2Yes3
Ebola in West Africa2013–nowUnknownYes11
Zika virus in Brazil and Colombia2015–nowYes12Yes10
Dengue fever in Hawaii and tropical Asian islands2015, 2017–nowYes13Yes14

GBS is an autoimmune disorder, in which the immune system attacks the peripheral nervous system. It causes muscle weakness, due to damage to nerve cells and their supporting structures.16 Different types of GBS feature different types of immune attack. Although it is a relatively rare event, GBS could be life threatening, with bulbar and respiratory involvement. It is reported that in two-thirds of patients, neuropathic GBS occurs after an infection.17 GBS is a known sequelae of Dengue infection,18 and has been reported in influenza virus, herpesvirus and hepatitis virus infections, etc.16,19 Literally, any virus infection has the potential to cause GBS. Due to the rising pandemics of Zika virus in recent years, GBS has become a focus of discussion. In 2013–2014, GBS was reported from the areas of Zika virus outbreaks, and in 2015, reported again in Oceania and the Americas. Statistically, during Zika pandemics in French Polynesia, among 28,000 persons under medical care, 38 (0.14%) patients developed GBS, compatible with the acute motor axonal neuropathy subtype of the disease.20

In recent years, virus-caused pandemics seem to have a trend of taking off, and the syndromes caused by these diseases have also showed some new and more complicating characteristics. One typical example is the reoccurrence of Zika virus. On its initial appearance in the 1950s, it seemed to be mild.21 As such, Zika virus infection was considered as benign throughout the 20th century.22 But, in the recent 2015 outbreak in Brazil, it was reported to be associated with GBS and microcephaly.23 Considering Dengue and Zika viruses are from the same Flavivirus family, it is not surprising that the symptoms of Zika infection are often confused with Dengue virus infection and Dengue-chikingunya super-infections when causing GBS.

In all the cases reported for the 2013–2015 Zika virus breakouts, the infected persons showed mild fevers, headaches and body pains. These symptoms are very similar to those of Dengue and chikingunya infections, two other viral diseases that are often endemic in the same areas and are also transmitted by Aedes mosquitoes. Indeed, this may have caused many Zika infections to be mistaken as Dengue or chikingunya. Considering the possibilities of super-infections of multiple viruses, it is very difficult to confirm that the associated GBS is due to which viral infection(s). Even though the example provided by this case report has significant clinical magnificence (without associated thrombocytopenia),15 the complication is very similar to concurrent Zika virus infection. Under specific conditions that cause respiratory emergency, the treatment used in this case report can be applied to GBS induced by Zika virus infection.

Although GBS is a rare event in virus infection, the lethal consequence needs proper treatment and that’s where we should provide corresponding care to the patients. In Table 1, the main viruses causing pandemics in recent years are listed. One thing worth noticing is that most of these viruses can cause GBS and/or respiratory emergency. As the emerging viruses like Zika virus have no proper vaccines to prevent infection, under a condition when there is a new virus pandemic without proper vaccines, the treatment of a severe lethal syndrome becomes the focus of emergency. This paper may provide some valuable references when coping with emerging viruses that can cause GBS and/or respiratory emergency.

Traditionally, the method to treat respiratory emergency usually involves surgical tracheostomy. In this case, percutaneous dilatational tracheostomy (PCT) was performed instead of classical tracheostomy. Compared to the old method, PCT has a smaller size of incision and quicker recovery. Also, PCT is supposed to be a bedside procedure that can be performed by every physician,24 with less assistance and material.25 These traits fit the requirements when there is a breakout of viruses and large numbers of patients need to be taken care of. PCT could be a potential life-saving method when facing certain future emerging virus attacks that cause respiratory emergency. Another critical method used in this case report is IV-Ig immune therapy. Based on the response of the patients while the treatments were going on, it is clear that IV-Ig here plays a key role in the patient’s recovery. However, this is not surprising, for IV-Ig immune therapy is already a routine method to treat GBS clinically.

In summary, although this case report provided a specific condition of combined chikungunya and Dengue infection, it could become very typical in future virus pandemics. The successful treatment of this condition provided valuable reference for emerging virus pandemics that may require a similar treatment for GBS and life-threatening breathing problems.

Abbreviations

GBS: 

Guillain-Barré syndrome

PCT: 

percutaneous dilatational tracheostomy

References

  1. Lew TW, Kwek TK, Tai D, Earnest A, Loo S, Singh K. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 2003;290:374-380 View Article PubMed/NCBI
  2. Oehler E, Fournier E, Leparc-Goffart I, Larre P, Cubizolle S, Sookhareea C. Increase in cases of Guillain-Barré syndrome during a Chikungunya outbreak, French Polynesia, 2014 to 2015. Euro Surveill 2015;20:30079 View Article PubMed/NCBI
  3. Singh A. Acute Respiratory Distress Syndrome: An Unusual Presentation of Chikungunya Fever Viral Infection. J Glob Infect Dis 2017;9:33-34 View Article PubMed/NCBI
  4. Craig AT, Butler MT, Pastore R, Paterson BJ, Durrheim DN. Acute flaccid paralysis incidence and Zika virus surveillance, Pacific Islands. Bull World Health Organ 2017;95:69-75 View Article PubMed/NCBI
  5. Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W. Guillain-Barré syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol 2012;175:1110-1119 View Article PubMed/NCBI
  6. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 2004;101:1356-1361 View Article PubMed/NCBI
  7. Piastra M, Onesimo R, De Luca D, Lancella L, Marzano L, De Rosa G. Measles-induced respiratory distress, air-leak and ARDS. Eur J Clin Microbiol Infect Dis 2010;29:181-185 View Article PubMed/NCBI
  8. Bush NE, Wheeler WM. Personal technology use by U.S. military service members and veterans: an update. Telemed J E Health 2015;21:245-258 View Article PubMed/NCBI
  9. Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016;387:1531-1539 View Article PubMed/NCBI
  10. Arzuza-Ortega L, Polo A, Perez-Tatis G, Lopez-Garcia H, Parra E, Pardo-Herrera LC. Fatal sickle cell disease and Zika virus infection in girl from Colombia. Emerg Infect Dis 2016;22:925-927 View Article PubMed/NCBI
  11. Mora-Rillo M, Arsuaga M, Ramirez-Olivencia G, de la Calle F, Borobia AM, Sanchez-Seco P. Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain. Lancet Respir Med 2015;3:554-562 View Article PubMed/NCBI
  12. Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S, Valour F. Zika virus infection complicated by Guillain-Barre syndrome—case report, French Polynesia, December 2013. Euro Surveill 2014;19:pii20720 View Article PubMed/NCBI
  13. Soares CN, Cabral-Castro M, Oliveira C, Faria LC, Peralta JM, Freitas MR. Oligosymptomatic dengue infection: a potential cause of Guillain Barre syndrome. Arq Neuropsiquiatr 2008;66:234-237 View Article PubMed/NCBI
  14. Yeh CY, Chen PL, Chuang KT, Shu YC, Chien YW, Perng GC. Symptoms associated with adverse dengue fever prognoses at the time of reporting in the 2015 dengue outbreak in Taiwan. PLoS Negl Trop Dis 2017;11:e0006091 View Article PubMed/NCBI
  15. Hariharan U, Chaudhary L, Bhasin N. Guillain-Barre syndrome following combined chikungunya and dengue infection: critical care management and future research. Explor Res Hypothesis Med 2017;2:30-32 View Article PubMed/NCBI
  16. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012;366:2294-2304 View Article PubMed/NCBI
  17. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005;366:1653-1666 View Article PubMed/NCBI
  18. Carod-Artal FJ, Wichmann O, Farrar J, Gascon J. Neurological complications of dengue virus infection. Lancet Neurol 2013;12:906-919 View Article PubMed/NCBI
  19. Lehmann HC, Hartung HP, Kieseier BC, Hughes RA. Guillain-Barré syndrome after exposure to influenza virus. Lancet Infect Dis 2010;10:643-651 View Article PubMed/NCBI
  20. Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika virus. N Engl J Med 2016;374:1552-1563 View Article PubMed/NCBI
  21. Dick GW. Zika virus. II. Pathogenicity and physical properties. Trans R Soc Trop Med Hyg 1952;46:521-534 View Article PubMed/NCBI
  22. Grossi-Soyster EN, LaBeaud AD: Clinical aspects of Zika virus. Curr Opin Pediatr. 2017;29:102-106 View Article PubMed/NCBI
  23. Sikka V, Chattu VK, Popli RK, Galwankar SC, Kelkar D, Sawicki SG. The emergence of zika virus as a global health security threat: A review and a consensus statement of the INDUSEM Joint Working Group (JWG). J Glob Infect Dis 2016;8:3-15 View Article PubMed/NCBI
  24. Friedman Y, Mayer AD. Bedside percutaneous tracheostomy in critically ill patients. Chest 1993;104:532-535 View Article PubMed/NCBI
  25. Barba CA, Angood PB, Kauder DR, Latenser B, Martin K, McGonigal MD. Bronchoscopic guidance makes percutaneous tracheostomy a safe, cost-effective, and easy-to-teach procedure. Surgery 1995;118:879-883 View Article PubMed/NCBI